Posts Tagged 'abbvie'

AndroGel Retrial Leads to Award and Another Finding of Negligence

androgel retrial leads to finding of negligenceWhen an AndroGel lawsuit brought against pharmaceutical manufacturer AbbVie resulted in a $150 million award for the Oregon resident who filed it, the legal world took notice. The award was unique not only for the amount, but also in the way the amount was distributed.

A Chicago jury awarded plaintiff Jesse Mitchell nothing in compensation for the injuries or medical costs he incurred after a heart attack he attributed to ...

continue reading...

First Testim Trial Ends with Decision in Favor of Drugmaker

testim trial sides with drugmakerTestim maker Endo International’s Auxilium unit emerged victorious in the first trial over whether its testosterone therapy drug caused a heart attack in a patient.

The Tennessee plaintiff had been prescribed Testim for what he described as chronic fatigue and had been applying the testosterone gel to himself for over 6 months. In July 2014, he suffered a heart attack and was subsequently hospitalized twice. His recovery since then has ...

continue reading...

Androgel Maker Faces Another Big Verdict

androgel faces 150 million dollar verdict in low-t trialYet again, a jury sent AbbVie, maker of the popular prescription testosterone drug Androgel, a loud and clear message. A federal jury in Chicago found that AbbVie misrepresented the dangers of using Androgel. And to make sure the drugmaker got their message, it also reached a verdict in excess of $140 million.

This most recent trial is the second bellwether case to be tried in the federal testosterone replacement therapy ...

continue reading...

Androgel Maker Ordered to Pay Up With $150 Million Verdict

Androgel maker loses case for $150 million verdictOne would think that a verdict of this magnitude would send a very loud, very clear message to Androgel maker AbbVie. Unfortunately, the testosterone therapy maker may actually escape paying on this verdict, calling into question whether the company will still “hear” the jury.

The $150 million testosterone verdict was just issued in the case of an Oregon man whose lawsuit accused AbbVie of hiding the risk of ...

continue reading...

AbbVie Unhappy with Testosterone MDL Bellwether Trial Selection

abbvie not happy with bellwether trail selectionAbbVie, maker of the popular testosterone therapy product AndroGel, has expressed dissatisfaction with the federal court’s bellwether trial selection process, Forbes reports. The U.S. District Court for the Northern District of Illinois has chosen AbbVie to defend in the first MDL testosterone lawsuit to go to trial. AbbVie, a defendant in the fast-growing Illinois testosterone therapy MDL, has been instructed to select 32 potential cases to be prepared for bellwether ...

continue reading...

Testosterone Therapy Lawsuits Not Letting Up as South Carolina Claim Joins MDL

more testosterone therapy lawsuits join multidistrict litigationThe most recent report from the U.S. Judicial Panel on Multidistrict Litigation shows 2,231 testosterone lawsuits included in the Illinois MDL —and there’s no sign that the flood of lawsuits will let up any time soon. According to the Public Access to Court Electronic Records (PACER) database, over 40 new testosterone lawsuits were filed in the last week alone. A testosterone lawsuit filed last month by a South Carolina couple ...

continue reading...
Page 1 of 2 12